Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Black Diamond Therapeutics
Biotech
Black Diamond, Ideaya mull registrational trials for cancer meds
Black Diamond's EGFR inhibitor and Ideaya's darovasertib are moving closer to registrational trials in lung and eye cancers, respectively.
Angus Liu
Sep 23, 2024 12:18pm
Amgen poaches Moderna CMO—Chutes & Ladders
Jun 16, 2023 9:30am
Former AbbVie R&D chief tapped to run Tessera—Chutes & Ladders
Jun 3, 2022 9:30am
Black Diamond runs into rocky terrain, trims 30% of workforce
Apr 25, 2022 11:17am
Black Diamond's glioblastoma drug slows tumor growth in mice
Nov 23, 2020 8:27am
A year after exiting stealth, Black Diamond wants a $100M IPO
Jan 6, 2020 8:21am